Korean J Anesthesiol.  2006 Jul;51(1):24-28. 10.4097/kjae.2006.51.1.24.

Comparison of Total Intravenous Anesthesia and Sevoflurane-Alfentanil Anesthesia for Laparoscopic Cholecystectomy

Affiliations
  • 1Department of Anesthesiology and Pain Medicine, Korea University School of Medicine, Seoul, Korea. mknim@hotmail.com

Abstract

BACKGROUND: The aim of this prospective, double-blind randomized study was to compare the clinical properties of sevoflurane-alfentanil with propofol-remifentanil anesthesia in patients undergoing a laparoscopic cholecystectomy.
METHODS
Forty patients (ASA physical status 1, 2) scheduled for elective surgery received total intravenous anesthesia (TIVA group) with remifentanil and propofol or sevoflurane-alfentanil. The TIVA group was induced with propofol 5 microgram/ml and remifentanil 4.5 ng/ml. The anesthesia was maintained with a continuous infusions of propofol 2.5 microgram/ml and remifentanil 3 ng/ml. The sevoflurane-alfentanil group was induced with alfentanil 15 microgram/kg and propofol 1.5 mg/kg IV. Maintenance was obtained with 2.0 vol% sevoflurane and a bolus of alfentanil 10microgram/kg IV where needed.
RESULTS
There were no significant differences in the systolic and diastolic blood pressure and heart rate between the two groups. There were no significant differences in the time to eye opening, the time to extubation, post-anesthetic recovery room stay time and the incidence of postoperative nausea and vomiting between the two groups.
CONCLUSIONS
Propofol-remifentanil (TIVA) and sevoflurane-alfentanil both provided satisfactory anesthesia for a laparoscopic cholecystectomy.

Keyword

alfentanil; propofol; remifentanil; sevoflurane; TIVA

MeSH Terms

Alfentanil
Anesthesia*
Anesthesia, Intravenous*
Blood Pressure
Cholecystectomy, Laparoscopic*
Heart Rate
Humans
Incidence
Postoperative Nausea and Vomiting
Propofol
Prospective Studies
Recovery Room
Alfentanil
Propofol
Full Text Links
  • KJAE
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr